Table 5.

Dyspnea scores in survived COVID-19 patients with pulmonary fibrosis during follow up.

	Dypnea score (mean ± SD)
Variable	At discharge	1st month	3rd month	6th month
Bilateral lung infiltrations
No	2.8 ± 0.1	1.9 ± 0.1	1.5 ± 0.1	1.0 ± 0.1
Yes	2.8 ± 0.1	2.2 ± 0.2	1.5 ± 0.2	1.3 ± 0.2
P†	.946	.086	.850	.002∗
Ground-glass opacity
No	2.8 ± 0.1	2.0 ± 0.1	1.3 ± 0.3	1.0 ± 0.1
Yes	3.0 ± 0.1	2.0 ± 0.1	1.6 ± 0.1	1.1 ± 0.1
P†	.419	.998	.476	.554
Honeycomb
No	2.8 ± 0.1	1.9 ± 0.1	1.4 ± 0.1	1.1 ± 0.1
Yes	3.0 ± .01	2.1 ± 0.1	1.9 ± .01	1.3 ± 0.2
P†	.142	.122	.022∗	.048∗
Consolidation
No	2.8 ± 0.1	2.0 ± 0.3	1.5 ± 0.1	1.1 ± 0.1
Yes	3.0 ± .01	2.0 ± 0.1	2.0 ± .01	1.1 ± 0.1
P†	.419	.928	.094	.398
ICU admission
No	2.6 ± 0.1	1.9 ± 0.1	1.3 ± 0.2	1.1 ± 0.1
Yes	2.9 ± 0.2	2.1 ± 0.1	1.6 ± 0.1	1.1 ± 0.1
P†	.025∗	.147	.150	.599
Mechanical ventilation
No	2.8 ± 0.1	1.9 ± 0.1	1.4 ± 0.1	1.1 ± 0.1
Yes	3.0 ± 0.1	2.1 ± 0.1	1.9 ± 0.1	1.1 ± 0.1
P†	.142	.122	.229	.738
High flow nasal canula
No	2.8 ± 0.1	2.0 ± 0.1	1.5 ± 0.1	1.1 ± 0.1
Yes	2.9 ± 0.1	2.0 ± 0.1	1.5 ± 0.2	1.1 ± 0.1
P†	.283	.917	.754	.971
Long term oxygen therapy
No	2.7 ± 0.1	1.9 ± 0.1	1.4 ± 0.1	1.1 ± 0.1
Yes	2.9 ± 0.1	2.1 ± 0.1	1.7 ± 0.1	1.2 ± 0.1
P †	.024∗	.168	.061	.370